NEW YORK (GenomeWeb) – Using a pan-cancer analysis called allele-specific copy number analysis of tumors (ASCAT), researchers at the Francis Crick Institute, the University of Leuven, and their colleagues developed a new type statistical model, […]
NEW YORK (GenomeWeb) – Omics firm IsoPlexis is developing an automated version of its single-cell analysis platform for use in large clinical trials of CAR-T therapies for blood cancers. The Branford, Connecticut-based company is using […]
INTRODUCTION: Many acute viral infections of the central nervous system (CNS) remain without etiological diagnosis. Specific treatment is available for only few of them; however, accurate diagnosis is essential for patient’s life and public health. […]
BACKGROUND: Recently, identification and functional studies of circular RNAs, a type of non-coding RNAs arising from a ligation of 3′ and 5′ ends of a linear RNA molecule, were conducted in mammalian cells with the […]
Venous thromboembolism (VTE) has a strong genetic component. This review summarizes what is known at the seventeen genes that are now well established to harbour VTE-associated genetic variants. In addition, it discusses additional candidate genes […]
About half of the global methane (CH4 ) emission is contributed by the methanogenic archaeal communities leading to a significant increase in global warming. This unprecedented situation has increased the ever growing necessity of evaluating […]
NEW YORK (GenomeWeb) – Thermo Fisher Scientific said today that it has partnered with Blueprint Medicines to develop and commercialize its Oncomine Dx Target Test as a companion diagnostic for Blueprint’s BLU-667 to identify RET […]
NEW YORK (GenomeWeb) – Exact Sciences reported after the close of the market on Monday that its third quarter revenues rose 158 percent year over year, driven by a 136 percent increase in the number […]
NEW YORK (GenomeWeb) – OncoDNA said today that CyberKnife Sigulda will market and distribute its tumor profiling solutions for clinical use in Latvia. Financial and other terms of the deal were not disclosed. Gosselies, Belgium-based […]
NEW YORK (GenomeWeb) – Targeted sequencing matched mutations to therapeutic options in more than half of the non-small cell lung cancer patients analyzed in a new study. NSCLC accounts for 85 percent to 90 percent […]
Copyright © 2022 | MH Magazine WordPress Theme by MH Themes